مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

218
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

142
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DISCOVERY OF NOVEL GLUCAGON RECEPTOR ANTAGONISTS USING COMBINED PHARMACOPHORE MODELING AND DOCKING

Pages

  1263-1287

Abstract

 Glucagon and the glucagon receptor are most important molecules control over blood glucose concentrations. These two molecules are very important to studies of type 2 diabetic patients. In literature, several classes of small molecule antagonists of the human glucagon receptor have been reported. GLUCAGON RECEPTOR ANTAGONIST could decrease hepatic glucose output and improve glucose control in diabetic patients. In this research, to identify novel and diverse leads for use in potent GLUCAGON RECEPTOR ANTAGONIST design, a LIGAND-BASED PHARMACOPHORE MODELING, was developed using the best conformations of training set compounds. The best five features pharmacophore model, called Hypo1, includes, hydrogen bond acceptors, two hydrophobic, and positive ionizable features, which has the highest correlation coefficient (0.805), cost difference (64.38), low RMS (2.148), as well as it shows a high goodness of fit and enrichment factor. The generated pharmacophore model has been validated by using a series of similar structures with varying affinities for the glucagon receptor. Then, the developed model has been applied as a search query in different database searching with the main objective of finding novel molecules which have the potential to be be modified into novel lead compounds. As a result, some hit molecules were introduced as final candidates by employing VIRTUAL SCREENING and molecular DOCKING procedure simultaneously. The results from pharmacophore modeling and molecular DOCKING are complementary to each other and could serve as a useful way for the discovery of potent small molecules as GLUCAGON RECEPTOR ANTAGONIST.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    JAFARI, FATANEH, Norouzi, Amin, & SHAHLAEI, MOHSEN. (2018). DISCOVERY OF NOVEL GLUCAGON RECEPTOR ANTAGONISTS USING COMBINED PHARMACOPHORE MODELING AND DOCKING. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 17(4), 1263-1287. SID. https://sid.ir/paper/288914/en

    Vancouver: Copy

    JAFARI FATANEH, Norouzi Amin, SHAHLAEI MOHSEN. DISCOVERY OF NOVEL GLUCAGON RECEPTOR ANTAGONISTS USING COMBINED PHARMACOPHORE MODELING AND DOCKING. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2018;17(4):1263-1287. Available from: https://sid.ir/paper/288914/en

    IEEE: Copy

    FATANEH JAFARI, Amin Norouzi, and MOHSEN SHAHLAEI, “DISCOVERY OF NOVEL GLUCAGON RECEPTOR ANTAGONISTS USING COMBINED PHARMACOPHORE MODELING AND DOCKING,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 17, no. 4, pp. 1263–1287, 2018, [Online]. Available: https://sid.ir/paper/288914/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button